SCHEMBL24811997

SCHEMBL24811997

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccn5)cc4)nc(-c4ccc5c(-c6ccc7ccccc7c6)c6ccccc6c(-c6ccc7ccccc7c6)c5c4)n3)cc2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
PKM P14618 2/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
KLF5 Q13887 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
DHODH Q02127 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DCTPP1 Q9H773 1/20 0.39
SIRT2 Q8IXJ6 2/20 0.38
CYP1A2 P05177 3/20 0.37
CYP1A1 P04798 2/20 0.37
CYP1B1 Q16678 2/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24811953 0.95 KDM4E (0.48) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL24812229 0.93 KDM4E (0.52) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL24810523 0.92 TSHR (0.46) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL15977912 0.91 KDM4E (0.50) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL15977456 0.91 KDM4E (0.49) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL275959 0.91 SMN1; SMN2 (0.48) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL15977771 0.91 SMN1; SMN2 (0.48) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL13658725 0.90 SMN1; SMN2 (0.50) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL24813350 0.90 KDM4E (0.44) KDM4ESMN1; SMN2LMNAMAPTPKM
SCHEMBL24812251 0.90 MAPT (0.46) KDM4ESMN1; SMN2LMNAMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885SMN1; SMN2 3245/4885LMNA 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.